Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke

Recruiting

Phase 2

Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke

Sponsor:

Silver Creek Pharmaceuticals

Code:

NCT05585606

Conditions

Acute Ischemic Stroke (AIS)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Placebo

scp776 (1.9 mg/kg)

scp776 (3.8 mg/kg)

scp776 (4.8 mg/kg)

scp776 (all dose levels)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Silver Creek Pharmaceuticals on 2025-04-24.